Patents by Inventor Darji Hirenkumar Jitendrakumar

Darji Hirenkumar Jitendrakumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral liquid compositions of Enzalutamide and method of manufacturing thereof
    Patent number: 12150930
    Abstract: The present invention relates to oral liquid formulations of Enzalutamide or pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipient. Further, the invention relates to providing an economical and technically advanced dosage form over existing dosage forms. In addition, the present invention also provides an improved process for preparation of Enzalutamide oral liquid formulation. The present invention further provides such compositions for the treatment of for the treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel.
    Type: Grant
    Filed: July 31, 2023
    Date of Patent: November 26, 2024
    Assignee: BDR Pharmaceuticals Int'l Pvt. Ltd.
    Inventors: Shah Dharmesh Mahendrabhai, Badiger Aravind Manappa, Sharma Mukeshkumar Subhashchandra, Trivedi Madhavkumar Dilipbhai, Choksi Rakshit Ketanbhai, Vora Pratik Ashwinbhai, Agrawal Vijay Ashok, Gandhi Prashant Kanaiyalal, Panchal Nimitkumar Harishchandra, Mori Nitin Merubhai, Jayaswal Nilay Manikant, Darji Hirenkumar Jitendrakumar
  • NOVEL ORAL LIQUID COMPOSITIONS OF ENZALUTAMIDE AND METHOD OF MANUFACTURING THEREOF
    Publication number: 20240058306
    Abstract: The present invention relates to oral liquid formulations of Enzalutamide or pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipient. Further, the invention relates to providing an economical and technically advanced dosage form over existing dosage forms. In addition, the present invention also provides an improved process for preparation of Enzalutamide oral liquid formulation. The present invention further provides such compositions for the treatment of for the treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel.
    Type: Application
    Filed: July 31, 2023
    Publication date: February 22, 2024
    Inventors: Shah Dharmesh Mahendrabhai, Badiger Aravind Manappa, Sharma Mukeshkumar Subhashchandr, Trivedi Madhavkumar Dilipbhai, Choksi Rakshit Ketanbhai, Vora Pratik Ashwinbhai, Agrawal Vijay Ashok, Gandhi Prashant Kanaiyalal, Panchal Nimitkumar Harishchandra, Mori Nitin Merubhai, Jayaswal Nilay Manikant, Darji Hirenkumar Jitendrakumar